Is screening for prostate cancer the current gold standard? - 'Yes'

European Journal of Cancer Part A

Volumn 33, Issue 3, 1997, Pages 354-356

  Lange, P H ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER SCREENING; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; REVIEW;

EID: 0031105724     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(96)00465-0     Document Type: Review

References (23)

1. Lange PH. Future studies in localized prostate cancer: what should we think? what can we do? J Urol. 152:1994;1932-1938.
2. Stamey T, Freiha F, McNeal J, Redwine E, Whittemore A, Schmid H. Localized prostate cancer: relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer. 71:1993;933-938.
3. Johansson JE, Adami H, Andersson SO, Bergstrom R, Holmberg L, Krusemo U. High 10-year survival rate in patients with early, untreated prostatic cancer. JAMA. 267:1992;2191.
4. Chodak GW, Thisted RA, Gerber GS, et al. Results of conservative management of clinical localized prostate cancer. N Engl J Med. 330:1994;242-248.
5. Fleming C, Wasson JH, Albertson PC, Barry MJ, Wennberg JE. A decision analysis of alternative treatment strategies for clinically localized prostate cancer. JAMA. 269:1993;2651.
6. Woolf SH. Screening for prostate cancer with prostate-specific antigen. An examination of the evidence. N Engl J Med. 333:1995;1401-1405.
7. Whitmore WF. Consensus development conference on the management of clinically localized prostate cancer. Overview: historical and contemporary. Natl Cancer Inst Monogr. 7:1988;7-11.
8. Kramer BS, Brown MJ, Orirok PC, Potosky AL, Gohagen JK. Prostate cancer screening: what we know and what we need to know. Ann Intern Med. 229:1993;914.
9. Wilt TJ, Brawer MK. The Prostate Cancer Intervention Versus Observation Trial: a randomized trial comparing radical prostatectomy versus expectant management for the treatment of clinically localized prostate cancer. J Urol. 152:1994;1910.
10. Lange PH. The next era for prostate cancer screening. JAMA. 269:1993;93-96.
11. Adolfsson J, Steineck G, Whitmore WM Jr. Recent results of management of palpable clinically localized prostate cancer. Cancer. 72:1993;310-322.
12. Lange PH. New information about prostate-specific antigen and the paradoxes of prostate cancer. JAMA. 273:1995;336-337.
13. Kassirer JP. The quality of care and the quality of measuring it. N Engl J Med. 329:1993;1253.
14. Tannebaum SJ. What physicians know. N Engl J Med. 329:1993;1268.
15. Roos NP, Wennberg JE, Malenka DJ. Morbidity and reoperation after open versus transurethral resection of the prostate for benign prostatic hypertrophy. N Engl J Med. 320:1989;1120.
16. Concato J, Horwitz RI, Feinstein AR, Elmore JG, Schiff SF. Problems of comorbidity in mortality after prostatectomy. JAMA. 267:1992;1077.
17. Beck JR, Kattan MW, Miles BJ. Critique of decision analysis for clinically localized prostate cancer. J Urol. 152:1994;1894-1899.
18. Zincke H, Bergstralh EJ, Blute ML, et al. Radical prostatectomy for clinically localized prostate cancer: long-term results of 1,143 patients from a single institution. J Clin Oncol. 12:1994;2254-2263.
19. Ohori M, Wheeler TM, Dunn JK, Stamey TA, Scardino PT. Pathological features in prognosis of prostate cancer detectable with current diagnostic tests. J Urol. 152:1994;1714-1720.
20. Epstein JI, Walsh PC, Carmichael M, Brendler CB. Pathological and clinical findings to predict tumor extent of nonpalpable (stage Tlc) prostate cancer. JAMA. 271:1994;368-374.
21. Dugan JA, Bostwick DG, Myers RP, Qian J, Bergstralh EJ, Oesterling JE. The definition and preoperative prediction of clinically insignificant prostate cancer. JAMA. 275:1996;288-294.
22. Gann PH, Hennekens CH, Stampfer MJ. A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. JAMA. 273:1994;289-294.
23. Gronberg H, Damber JE, Jonsson H, Lenne P. Patients age as a prognostic factor in prostate cancer. J Urol. 152:1994;892-895.